{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T01:07:14Z","timestamp":1781226434774,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The purpose of this study was to investigate the role of corneal crosslinking (CXL) of grafts during keratoplasty (KP) in patients with refractory corneal melting (CM). This is a retrospective case series reporting the clinical outcomes of patients who received a crosslinked corneal graft during penetrating or deep anterior lamellar KP for refractory infectious or sterile CMs. Outcome measures were the recurrence of CM, the time required for epithelial healing following KP, incidence of complications, and necessity for re-transplantation. Twenty eyes of 18 patients with a follow-up of 29.2\u2009\u00b1\u200915.8\u00a0months were included in this study. All but two eyes had undergone previous KPs during the course of their disease (mean 1.9\u2009\u00b1\u20091.6). After CXL-enhanced KP, three eyes (15%) experienced recurrence of CM, three eyes developed an infectious keratitis and six eyes (30%) required a re-transplantation (three of them within 12\u00a0months). The mean time to epithelium closure after CXL-enhanced KP was 63\u2009\u00b1\u200990\u00a0days. The number of postoperative re-transplantations was significantly lower than the number of KPs performed before the CXL-enhanced transplantation (before CXL 1.9\u2009\u00b1\u20091.6 vs after CXL: 0.3\u2009\u00b1\u20090.57, p\u2009=\u20090.002). To conclude,\u00a0CXL of the graft at the time of keratoplasty decreased the need for re-transplantations. However, further studies are needed in order to establish its role in the management of severe CM necessitating therapeutic corneal transplantation.<\/jats:p>","DOI":"10.1038\/s41598-024-66629-2","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T12:02:00Z","timestamp":1720699320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The role of graft cross-linking during keratoplasty in patients with corneal melting"],"prefix":"10.1038","volume":"14","author":[{"given":"Raphael","family":"Kilian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Schmidinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Lammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,11]]},"reference":[{"key":"66629_CR1","volume-title":"Cornea: Fundamentals, Diagnosis and Management","author":"JH Krachmer","year":"2021","unstructured":"Krachmer, J. H., Mannis, M. J. & Holland, E. J. Cornea: Fundamentals, Diagnosis and Management 5th edn. (Elsevier Inc., 2021).","edition":"5"},{"key":"66629_CR2","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.2147\/OPTH.S336986","volume":"15","author":"U Reinprayoon","year":"2021","unstructured":"Reinprayoon, U. et al. Survival outcome and prognostic factors of corneal transplantation: A 15\u00a0year retrospective cohort study at King Chulalongkorn Memorial Hospital. Clin. Ophthalmol. 15, 4189\u20134199 (2021).","journal-title":"Clin. Ophthalmol."},{"key":"66629_CR3","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.2147\/OPTH.S385782","volume":"16","author":"S Sabhapandit","year":"2022","unstructured":"Sabhapandit, S., Murthy, S. I., Sharma, N. & Sangwan, V. S. Surgical management of peripheral ulcerative keratitis: Update on surgical techniques and their outcome. Clin. Ophthalmol. 16, 3547\u20133557 (2022).","journal-title":"Clin. Ophthalmol."},{"key":"66629_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-023-05994-6","author":"RPC Manns","year":"2023","unstructured":"Manns, R. P. C. et al. Use of corneal cross-linking beyond keratoconus: A systemic literature review. Graefes Arch. Clin. Exp. Ophthalmol. https:\/\/doi.org\/10.1007\/s00417-023-05994-6 (2023).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"1","key":"66629_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/02713680490513182","volume":"29","author":"E Spoerl","year":"2004","unstructured":"Spoerl, E., Wollensak, G. & Seiler, T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr. Eye Res. 29(1), 35\u201340 (2004).","journal-title":"Curr. Eye Res."},{"key":"66629_CR6","doi-asserted-by":"publisher","first-page":"101705","DOI":"10.1016\/j.ajoc.2022.101705","volume":"28","author":"A Tillmann","year":"2022","unstructured":"Tillmann, A. et al. Acute corneal melt and perforation\u2014A possible complication after riboflavin\/UV-A crosslinking (CXL) in keratoconus. Am. J. Ophthalmol. Case Rep. 28, 101705 (2022).","journal-title":"Am. J. Ophthalmol. Case Rep."},{"issue":"8","key":"66629_CR7","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/eye.2012.136","volume":"26","author":"P Hossain","year":"2012","unstructured":"Hossain, P. The corneal melting point. Eye 26(8), 1029\u20131030 (2012).","journal-title":"Eye"},{"key":"66629_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ajo.2020.02.024","volume":"214","author":"J Lammer","year":"2020","unstructured":"Lammer, J. et al. Endothelial safety and efficacy of ex vivo collagen cross-linking of human corneal transplants. Am. J. Ophthalmol. 214, 127\u2013133 (2020).","journal-title":"Am. J. Ophthalmol."},{"key":"66629_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2174\/1874364101307010079","volume":"7","author":"GD Kymionis","year":"2013","unstructured":"Kymionis, G. D. et al. Cross-linking as an adjuvant treatment for tectonic corneal lamellar graft preparation. Open Ophthalmol. J. 7, 79\u201381 (2013).","journal-title":"Open Ophthalmol. J."},{"issue":"6","key":"66629_CR10","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1097\/ICO.0000000000000830","volume":"35","author":"G T\u00f3th","year":"2016","unstructured":"T\u00f3th, G. et al. In situ corneal cross-linking for recurrent corneal melting after Boston type 1 keratoprosthesis. Cornea 35(6), 884\u2013887 (2016).","journal-title":"Cornea"},{"issue":"6","key":"66629_CR11","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/ICL.0000000000000081","volume":"40","author":"MC Robert","year":"2014","unstructured":"Robert, M. C., Arafat, S. N. & Ciolino, J. B. Collagen cross-linking of the Boston keratoprosthesis donor carrier to prevent corneal melting in high-risk patients. Eye Contact Lens 40(6), 376\u2013381 (2014).","journal-title":"Eye Contact Lens"},{"issue":"11","key":"66629_CR12","doi-asserted-by":"publisher","first-page":"e0208163","DOI":"10.1371\/journal.pone.0208163","volume":"13","author":"S Wan","year":"2018","unstructured":"Wan, S., Cheng, J., Dong, Y. & Xie, L. Epithelial defects after penetrating keratoplasty in infectious keratitis: An analysis of characteristics and risk factors. PLoS One 13(11), e0208163 (2018).","journal-title":"PLoS One"},{"issue":"1","key":"66629_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00003226-200401000-00008","volume":"23","author":"G Wollensak","year":"2004","unstructured":"Wollensak, G., Spoerl, E., Wilsch, M. & Seiler, T. Keratocyte apoptosis after corneal collagen cross-linking using riboflavin\/UVA treatment. Cornea 23(1), 43\u201349 (2004).","journal-title":"Cornea"},{"issue":"5","key":"66629_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.14715\/cmb\/2022.68.5.9","volume":"68","author":"H Xing","year":"2022","unstructured":"Xing, H. & Oyang, H. Evaluation of corneal tissue changes after collagen cross-linking with ultraviolet and riboflavin A. Cell. Mol. Biol. 68(5), 72\u201376 (2022).","journal-title":"Cell. Mol. Biol."},{"issue":"3","key":"66629_CR15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41433-019-0517-9","volume":"34","author":"O Azevedo Magalhaes","year":"2020","unstructured":"Azevedo Magalhaes, O., Shalaby Bardan, A., Zarei-Ghanavati, M. & Liu, C. Literature review and suggested protocol for prevention and treatment of corneal graft rejection. Eye 34(3), 442\u2013450 (2020).","journal-title":"Eye"},{"issue":"8","key":"66629_CR16","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1097\/01.TP.0000158022.62059.F2","volume":"79","author":"F Birnbaum","year":"2005","unstructured":"Birnbaum, F., B\u00f6hringer, D., Sokolovska, Y., Sundmacher, R. & Reinhard, T. Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: A retrospective study. Transplantation 79(8), 964\u2013968 (2005).","journal-title":"Transplantation"},{"issue":"12","key":"66629_CR17","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1097\/TP.0000000000002938","volume":"103","author":"WJ Armitage","year":"2019","unstructured":"Armitage, W. J. et al. High-risk corneal transplantation: Recent developments and future possibilities. Transplantation 103(12), 2468\u20132478 (2019).","journal-title":"Transplantation"},{"issue":"6","key":"66629_CR18","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.ophtha.2007.08.049","volume":"115","author":"DT Tan","year":"2008","unstructured":"Tan, D. T. et al. Penetrating keratoplasty in Asian eyes: The Singapore corneal transplant study. Ophthalmology 115(6), 975\u2013982 (2008).","journal-title":"Ophthalmology"},{"issue":"5","key":"66629_CR19","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ophtha.2008.12.029","volume":"116","author":"AS Kitzmann","year":"2009","unstructured":"Kitzmann, A. S., Goins, K. M., Sutphin, J. E. & Wagoner, M. D. Keratoplasty for treatment of Acanthamoeba keratitis. Ophthalmology 116(5), 864\u2013869 (2009).","journal-title":"Ophthalmology"},{"issue":"1","key":"66629_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/bjo.85.1.91","volume":"85","author":"MD Daniell","year":"2001","unstructured":"Daniell, M. D., Dart, J. K. & Lightman, S. Use of cyclosporin in the treatment of steroid resistant post-keratoplasty atopic sclerokeratitis. Br. J. Ophthalmol. 85(1), 91\u201392 (2001).","journal-title":"Br. J. Ophthalmol."},{"issue":"5","key":"66629_CR21","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.ophtha.2007.07.018","volume":"115","author":"M Tomita","year":"2008","unstructured":"Tomita, M., Shimmura, S., Tsubota, K. & Shimazaki, J. Postkeratoplasty atopic sclerokeratitis in keratoconus patients. Ophthalmology 115(5), 851\u2013856 (2008).","journal-title":"Ophthalmology"},{"issue":"2","key":"66629_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00417-007-0684-4","volume":"246","author":"F Bock","year":"2008","unstructured":"Bock, F., K\u00f6nig, Y., Kruse, F., Baier, M. & Cursiefen, C. Bevacizumab (avastin) eye drops inhibit corneal neovascularization. Graefes Arch. Clin. Exp. Ophthalmol. 246(2), 281\u2013284 (2008).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"2","key":"66629_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/ICO.0000000000002406","volume":"40","author":"F Schaub","year":"2021","unstructured":"Schaub, F. et al. Corneal crosslinking to regress pathologic corneal neovascularization before high-risk keratoplasty. Cornea 40(2), 147\u2013155 (2021).","journal-title":"Cornea"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-66629-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-66629-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-66629-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T12:06:33Z","timestamp":1720699593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-66629-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,11]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["66629"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-66629-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,11]]},"assertion":[{"value":"29 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16026"}}